Literature DB >> 24569315

Lower vancomycin serum trough concentrations might not be the answer.

Andrea Hahn1, Alexander A Vinks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24569315      PMCID: PMC3937855          DOI: 10.1097/INF.0000000000000003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

1.  A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population.

Authors:  P Lamarre; D Lebel; M P Ducharme
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.

Authors:  Adam Frymoyer; B Joseph Guglielmo; Adam L Hersh
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

Review 3.  Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.

Authors:  R W Jelliffe; A Schumitzky; D Bayard; M Milman; M Van Guilder; X Wang; F Jiang; X Barbaut; P Maire
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

4.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

Authors:  Ravina Kullar; Susan L Davis; Donald P Levine; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

  5 in total
  2 in total

Review 1.  Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics.

Authors:  Kevin J Downes; Andrea Hahn; Jason Wiles; Joshua D Courter; Alexander A Vinks
Journal:  Int J Antimicrob Agents       Date:  2013-12-17       Impact factor: 5.283

2.  Prospective validation of neonatal vancomycin dosing regimens is urgently needed.

Authors:  Anaïs Vandendriessche; Karel Allegaert; Veerle Cossey; Gunnar Naulaers; Veroniek Saegeman; Anne Smits
Journal:  Curr Ther Res Clin Exp       Date:  2014-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.